Trials / Unknown
UnknownNCT04636996
Effects of AI Assisted Follow-up Strategy on Secondary Prevention in CABG Patients
Effects of Artificial Intelligence Assisted Follow-up Strategy Based on a New Remote Contactless Sleep Monitoring System on Secondary Prevention in Patients Received Coronary Artery Bypass Grafting Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The present study is trying to find out whether artificial intelligence assisted follow-up strategy will improve secondary prevention in CABG patients. In addition, we will test whether rural patients may have more benefits under the new follow-up strategy based on the artificial intelligence device compared with urban patients.
Detailed description
There are a large population of coronary heart disease patients in China, which needs more attention to optimize the secondary prevention and improve the prognosis. Secondary prevention has been showing the effects of improving symptoms, preventing disease progression, improving prognosis, and reducing mortality in patients received coronary artery bypass grafting (CABG) surgery. In this study, we are trying to evaluate the effectiveness of artificial intelligence (AI) assisted follow-up strategy on secondary prevention for patients received CABG surgery. And we are trying to find out whether there is difference in secondary prevention of coronary heart disease between urban and rural patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | artificial intelligence assisted follow-up | We will use a new portable artificial intelligence assisted device to monitor the patients' postoperative heart rate and sleep quality, guiding the following follow-up process |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2022-09-30
- Completion
- 2022-12-31
- First posted
- 2020-11-19
- Last updated
- 2020-11-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04636996. Inclusion in this directory is not an endorsement.